BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18279617)

  • 1. [Smac as a predictive marker of tumor response to preoperative radiotherapy in rectal cancer].
    Pan ZZ; Lin JZ; Wan DS
    Ai Zheng; 2008 Feb; 27(2):178-82. PubMed ID: 18279617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
    Zlobec I; Steele R; Compton CC
    Cancer; 2005 Dec; 104(11):2517-21. PubMed ID: 16222693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
    Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy.
    Zlobec I; Vuong T; Compton CC
    Cancer; 2006 Jan; 106(2):284-6. PubMed ID: 16315248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in peripheral blood: a novel marker for therapy response in locally advanced rectal cancer patients undergoing preoperative chemoradiation.
    Zitt M; Zitt M; Müller HM; Dinnewitzer AJ; Schwendinger V; Goebel G; De Vries A; Amberger A; Weiss H; Margreiter R; Ofner D; Oberwalder M
    Dis Colon Rectum; 2006 Oct; 49(10):1484-91. PubMed ID: 17019657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
    Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
    Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
    Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of preoperative radiotherapy as an adjunctive approach on proliferation and apoptosis of cancer cells in rectal cancer].
    Liu FK; Chen C; Qi XP; Xu Z; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):71-3. PubMed ID: 16149007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
    Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
    Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation.
    Willett CG; Warland G; Coen J; Shellito PC; Compton CC
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):57-61. PubMed ID: 7721640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
    Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of growth hormone receptor expression to preoperative radiosensitivity of rectal cancer patients].
    Wu XY; Xu Z; Chen C; Liu FK; Li JS
    Ai Zheng; 2006 Sep; 25(9):1162-7. PubMed ID: 16965663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
    De Oliveira Lima F; De Oliveira Costa H; Barrezueta LF; Fujiyama Oshima CT; Silva JA; Gomes TS; Pinheiro N; Neto RA; Franco M
    Oncol Rep; 2009 Aug; 22(2):295-303. PubMed ID: 19578769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
    Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.